Quality of life and adherence to treatment in patients with benign prostatic hyperplasia treated with tamsulosin 0.4 mg/dutasteride 0.5 mg for 12 weeks.

Quality of life and adherence to treatment in patients with benign prostatic hyperplasia treated with tamsulosin 0.4 mg/dutasteride 0.5 mg for 12 weeks.

Introduction Benign prostatic hyperplasia is defined as benign growth of the prostate, accompanied by lower urinary tract symptoms. This is a public health problem in the elderly population. Treatment can be clinical or surgical. Objective To assess the quality of life, satisfaction and adherence to...

Full description

Saved in:
Bibliographic Details
Main Author: Gomez-Cobos , Vladimir (author)
Other Authors: Medina , Esteban (author), Ribadeneira-Espinoza, Marco (author), Romero-Cortez , Francisco (author), Romero-Proaño, Patricio (author)
Format: article
Language:spa
Published: 2023
Subjects:
Hiperplasia Prostática
Adherencia al tratamiento
calidad de vida
prostatic hyperplasia
treatment adherence and compliance
quality of Life
Online Access:https://revistadigital.uce.edu.ec/index.php/CIENCIAS_MEDICAS/article/view/4435
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://revistadigital.uce.edu.ec/index.php/CIENCIAS_MEDICAS/article/view/4435

Similar Items